The VDAC1-based R-Tf-D-LP4 Peptide as a Potential Treatment for Diabetes Mellitus

The VDAC1-based R-Tf-D-LP4 Peptide as a Potential Treatment for Diabetes Mellitus

Diabetes mellitus is a metabolic disorder approaching epidemic proportions. Non-alcoholic fatty liver disease (NAFLD) regularly coexists with metabolic disorders, including type 2 diabetes, obesity, and cardiovascular disease. Recently, we demonstrated that the voltage-dependent anion channel 1 (VDA...

Full description

Bibliographic Details
Main Authors: Srinivas Pittala, Idan Levy, Soumasree De, Swaroop Kumar Pandey, Nataly Melnikov, Tehila Hyman, Varda Shoshan-Barmatz
Format: Article
Language:English
Published: MDPI AG 2020-02-01
Series:Cells
Subjects:
β-cells
high-fat diet
mitochondria
type 2 diabetes
vdac1-based r-tf-d-lp4 peptide
Online Access:https://www.mdpi.com/2073-4409/9/2/481

Internet

https://www.mdpi.com/2073-4409/9/2/481

Similar Items